Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion type Assertion NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_head.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion description "[These findings suggest that VHL inactivation leads to preferential HIF-2 activation and CCND1 expression as described previously in VHL-defective renal cell carcinoma cell lines but not in other cell types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_provenance.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion evidence source_evidence_literature NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_provenance.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion SIO_000772 16954163 NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_provenance.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion wasDerivedFrom befree-2016 NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_provenance.
- NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_assertion wasGeneratedBy ECO_0000203 NP567790.RAa0UHdS5AlBqpJ8VyVCPxn9SDxF5qXLjCZSgT3ZqJ6X4130_provenance.